High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments
- PMID: 32196108
- DOI: 10.1093/pm/pnaa057
High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments
Comment in
-
Response to Dr. Wee.Pain Med. 2020 Oct 1;21(10):2604. doi: 10.1093/pm/pnaa056. Pain Med. 2020. PMID: 32457998 No abstract available.
Comment on
-
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.Pain Med. 2020 Mar 1;21(3):576-585. doi: 10.1093/pm/pnz331. Pain Med. 2020. PMID: 31904855 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources